XENE position history
The shares of Xenon Pharmaceuticals (XENE) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 96,519 shares, $4.3M, 0.60% of portfolio, New
- 2026 Q1: 51,345 shares, $3M, 0.46% of portfolio, Reduce −46.8%
- 2026 Q2: 51,345 shares, $3.1M, 0.43% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|